In additiion, only one African study focused on breast cancer therapy; Abdeljaoued et al. showed that male Tunisian breast cancer patients with high FOXM1 expression exhibited significantly lower response rates to chemo- and hormone therapy than those with low FOXM1 expression [62]. Here, FOXM1 is linked to breast cancer.